Furthermore, whether the tumor was located in head and neck or extremity or trunk, the four-DNA methylation signature performed well in differentiating low- and high-risk groups, and patients in high-risk groups showed a trend towards worse OS ( Figure 3—figure supplement 4 ).
← all excerpts
A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.
1
—
—